[Oncology Rotation] Done by: Maha Al-Molaiki,Pharm D, Candidate,KSU
|
|
- Janis Andrews
- 5 years ago
- Views:
Transcription
1 [Oncology Rotation] Done by: Maha Al-Molaiki,Pharm D, Candidate,KSU
2 Introduction Epidemiology Etiology Pathogenesis Diagnosis Clinical Features Classifications 5-Years Survival Rate Treatment Modalities Case Presentation
3 It is a tumor located mainly in the cerebellum and sometimes found in the brainstem The most common malignant CNS tumor in children (age 3-8) Rarely seen in adults Christina Wong et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol. Feb
4 It occurs in 15-20% of all pediatric brain tumors In children up to 15 years of age the incidence is 0.5 per 100,000 cases It is Known as a PNET (Primative Neuro-Ectodermal Tumor) Christina Wong et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol. Feb
5 Asif Mehmood et al. KFSH&RC Annual Report 2011
6 Asif Mehmood et al. KFSH&RC Annual Report 2011
7 Genetic abnormalities have been found in medulloblastomas, By: The loss of 17p frequently occurring in association with duplication of the characteristic isochromosome 17q abnormality The p53 tumor suppressor gene is located in the short arm of the 17 chromosome, this has led to the abnormality in the p53 gene may underlie the development of medulloblastoma (Parsons et al 2011), (Takei et al 2009)
8 As the tumor grows, obstruction of cerebrospinal fluid (CSF) passage through the fourth ventricle resulting in hydrocephaly The tumor may spread contiguously to the floor of the fourth ventricle: Anteriorly to the brainstem Inferiorly to the cervical spine Superiorly above the tentorium Christina Wong et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol. Feb
9 Magnetic Resonance Imaging(MRI) of the neuroaxis Lumbar puncture: Medulloblastoma can metastasize throughout the central nervous system Cytological tests done on the sample to determine if neoplastic cells are present Christina Wong et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol. Feb
10 Packer RJet al., Embryonal and pineal region tumors. In: Pizzo PA, Poplack DG, eds.: Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams and Wilkins, 2011 Symptoms are mainly due to secondary increased intracranial pressure due to blockage of the fourth ventricle Children with medulloblastoma commonly present with the following: Abrupt onset of headaches Vomiting Lethargy Unsteadiness, including truncal unsteadiness Some degree of nystagmus Papilledema
11 Tumour Classification T1 T2 T3a T3b T4 Description Greatest tumour dimension <3cm Greatest tumour dimension >3cm Greatest tumour dimension >3cm with spread into the aqueduct of Sylvius and/or foramen of Luschka, cerebral subarachnoid space, third or lateral ventricles Greatest tumour dimension >3cm with unequivocal spread into the brainstem; for T3b, surgical staging may be used in the absence of involvement at imaging Greatest tumour dimension >3cm with spread beyond the aqueduct of Sylvius and/or the foramen magnum Chang CH et alan operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969 Dec
12 Metastasis Classification M0 M1 M2 M3 M4 Description No evidence of gross subarachnoid or hematogenous metastasis Microscopic tumour cells in cerebrospinal fluid Gross nodular seeding in cerebellum Gross nodular seeding in spinal subarachnoid space Metastasis beyond cerebrospinal axis Chang CH et alan operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969 Dec
13 Giles W. Robinson et al., American Brain Tumor Association., % 80% children with average-risk medulloblastoma can be expected to be alive and free of disease five years from diagnosis 60% 65% children with highrisk disease, effective therapy is possible and results in longterm disease control 30% 50% Outcome for infants is poorer, but for those infants with localized disease at the time of diagnosis
14 Jakacki RI et aloutcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: COG Phase I/II study. J Clin Oncol 2012.
15 Jakacki RI et aloutcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: COG Phase I/II study. J Clin Oncol 2012.
16 Cisplatin Side Effects Etoposide Cyclophosphami de Vincristine Bone Marrow Hypotension Cardiotoxicity Neurotoxicity Suppression Extravasation GI toxicity Hyperuricemia Infusion Site reaction Bone Marrow Suppression Bone Marrow Suppression Hemorrhagic Cystitis Pulmonary Toxicities Respiratory Effect Uric Acid Nephropathy Neurotoxicity Wound Healing Ototoxicity Impairment Nephrotoxicity Lexi-Comp,2014
17 Monitoring Parameters Cisplatin Etoposide Cyclophosphami de Vincristine Renal function test (Scr,BUN,Clcr) Electrolytes(Mg,C a,k) CBC(weekly) Liver function test CBC Liver function Test Albumin Vital Signs(BP) Renal Function Test Signs/Symptoms of Hemorrhagic Cystitis CBC BUN Serum Electrolyte Electrolytes(Na) CBC Constipation Signs/Symptoms of Neuropathy Lexi-Comp,2014
18 Case Presentation
19 F.D. is an 8 years old girl K/C of: omedulloblastoma stage IV Maintained on: ochemotherapy Protocol oradiation
20 Fever Cough SOB
21 Ataxia with unsteady gait Brain tumor was resected, patient needs further chemotherapy management
22 The patient went to Al Kharj Hospital and they did CT brain that showed left cerebellar lesion.so, she referred to PSMMC for further management and surgical resection On the 29 th -Aug-2013 The Patient presented to the hospital with history of headache, vomiting and neutropenia for the last four days. Her parents Brought her to PSMMC hospital due to the low oral intake
23 Then the patient initially presented to the Neurosurgery team with unsteady gait On the 15 th September-2013 MRI done for her and showed a mass brain tumor, for which she was taken for surgical resection by the Neurosurgery team On the 16 th September-2013 histopathology reported as medulloblastoma anaplastic
24 The child was diagnosed as medulloblastoma Stage IV On the 10 th November-2013 They received the patient in a good condition, active, walking with no neurological deficits, Vitally and hemodynamically stable
25 On the 20 th -Mar-2014 The patient was started on IV fluids only and finished the first cycle of chemotherapy in which she received cisplatin and of VP16(Etoposide) for 21 days. Also, finished her radiotherapy on 7 th - January 2014 She is due for cycle 2 to receive cyclophosphamide and Vincristine
26 Bronchial asthma Maintained on: osalbutamol Inhaler 100mcg/dos 1 PUFB PRN Neurofibromatosis type I
27 The patient underwent craniotomy and resection and after the surgery the patient transferred to PICU and stayed for two days there
28 Giles W. Robinson et al., American Brain Tumor Association.,2012. Medulloblastoma is not an inherited disease because the genetic changes tend to only occur inside the tumor cells
29 Medications Salbutamol Inhaler 100mcg/dos 2 puffs PO Q6hr PRN Co-Trimoxazole 240mg/5ml Susp,5ml Q12hr 2 days aweek (Sun,Mon) Specific Mouth Wash 5ml Fusidic Acid 2% Cream Apply to affected area FOUR times daily X2 WKS Fluticasone 250mcg Inha 1 puff PO BID Filgrastim inj (GC-SF) 300MCG,Inj SQ 0.1 ml(30mcg),od,x10 DAYS
30 The patient not pale, jaundiced or cyanosed Vital signs: BP: 117/82mmHg Weight: 19kg Height: 129cm BMI: 11.4 kg/m2 Temperature: 37.8C Oxygen saturation: 97% on room air Chest: Bilateral Cripitations Abdomen: Hepatomegaly
31 HEMATOLOGY WBC 15.9 RBC 3.69 HGB 11 Hct Plt 260 Neut A 13.6 BIOCHEMISTRY Na 137 K 3.9 Urea 3.2 Scr 38 C.Ca 2.27 Ph 1.38 Mg 0.75 Glucose 4.8 Albumin 45 ALP 113 AST 22 ALT 15 Gamma GT 12 Alkaline Phosphatase 144 High Low
32 s o A P Daily Cough more at night and early morning BP 110/52 Temp 36.7 RR30 PO2 98% WBC 5.1 RBC 3.16 HGB 9.7 Hct Plt 214 Neut A 4.2 Na 140 K3.5 Urea 1 Scr 35 C.Ca2.43 Ph1.14 Mg0.68 An 8 yrs old girl k/c of M.B. and B.A. Medications: Add Flixotide (Fluticasone)125mcg 1Puff BID Paracetamol 300mg PO q4-6 hr PRN(for fever) Ventolin (Sulbutamol)2 Puffs by mouth TID Bactrim 240mg PO BID(Sun,Mond) Tazocin 1.7g IV Q6hr day 3
33 s o A P Daily Cough more at night and early morning BP 108/60 Temp 36.7 RR30 PO2 98% WBC 2.5 RBC 3.43 HGB 10.4 Hct Plt 307 Neut A 1.1 Na 135 K3.8 Urea 2.6 Scr 41 C.Ca2.36 Ph1.46 Mg0.83 An 8 yrs old girl k/c of M.B. and B.A. Medications: D/C Bactrim 240mg PO BID(Sun,Mond) Tazocin 1.7g IV Q6hr day6 Add Etoposide 27mg(start date 7 th -May) Add Cisplatin 35mg IV(start date 7 th -May) Add Granisetron 0.4mg(start date 7 th May) Add Septrin 5ml(start date 7 th -May)
34 s o A P Increase vomiting cough improved BP 101/52 Temp 36.7 RR30 PO2 98% WBC 17.5 RBC 3.43 HGB 10.4 Hct Plt 307 Neut A Na 133 K 3.5 Urea 3.4 Scr 43 C.Ca2.30 Ph1.40 Mg0.99 An 8 yrs old girl k/c of M.B. and B.A. Medications: Tazocin 1.7g IV Q6hr day8 D/C Etoposide 27mg OD (On 9 th May) D/C Cisplatin 35mg IV(On 7 th May) Granisetron 0.4mg Septrin 5ml Add Dexamethasone 2mg (start date 9 th -May) one dose only(stat) Add GCSF 95mcg SQ OD (start date 8 th May)
35
36 Discharge Medications Filgrastim (GC-SF) 300mcg,Inject 0.1 ml(30mcg)sq OD for 10 days Granisetron 0.2MG/ML SUSP 2 ml PO BID for 4 days Co-Trimoxazole 240mg/5ml Suspens 5ml BID Two days aweek Friday and Saturday for 1 month Salbutamol Resp Soln 5mg/ml 20ml 2 puffs PO Q6hr PRN Fluticasone 125mcg Inhaler 1 puff PO BID
37
38
CHAPTER 11 Tumors Originating in the Brain Medulloblastomas, PNETs and Ependymomas
Tumors Originating in the Brain Medulloblastomas, PNETs and Ependymomas Foolishly, I waited 7 months before I joined this (or any) group. By that time, my son had radiation, chemo, and a recurrence of
More informationUpdate on Pediatric Brain Tumors
Update on Pediatric Brain Tumors David I. Sandberg, M.D. Director of Pediatric Neurosurgery & Associate Professor Dr. Marnie Rose Professorship in Pediatric Neurosurgery Pre-talk Questions for Audience
More informationPediatric Oncology. Vlad Radulescu, MD
Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common
More informationWHAT ARE PAEDIATRIC CANCERS
WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM MEDULLOBLASTOMA AND PNET CNS Site Group Medulloblastoma and PNET Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2. PREVENTION
More informationProtocol for management of patients with pineal region tumours v1
Protocol for management of patients with pineal region tumours v1 West Midlands Cancer Alliance Coversheet for Cancer Alliance Expert Advisory Group Agreed Documentation This sheet is to accompany all
More informationCase Report Tackling a Recurrent Pinealoblastoma
Case Reports in Oncological Medicine, Article ID 135435, 4 pages http://dx.doi.org/10.1155/2014/135435 Case Report Tackling a Recurrent Pinealoblastoma Siddanna Palled, 1 Sruthi Kalavagunta, 1 Jaipal Beerappa
More informationULYRICE. Protocol Code. Lymphoma. Tumour Group. Dr. Laurie Sehn. Contact Physician
BCCA Protocol Summary for the Treatment of Relapsed or Refractory Advanced Stage Aggressive B-Cell Non-Hodgkin s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and rituximab Protocol Code Tumour Group
More informationDr.Dafalla Ahmed Babiker Jazan University
Dr.Dafalla Ahmed Babiker Jazan University Brain tumors are the second commonest malignancy in children Infratentorial tumors are more common As a general rule they do not metastasize out of the CNS, but
More informationChildhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ )
1 di 10 27/06/2016 08.16 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationLEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University
LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish
More informationMANAGEMENT OF LUNG CANCER CYTOTOXIC AND TARGETED THERAPY TOXICITIES
MANAGEMENT OF LUNG CANCER CYTOTOXIC AND TARGETED THERAPY TOXICITIES CCP Conference Oct 27, 2017 Rick Prayag Pharmacist Lung DSG PRESENTER DISCLOSURE Faculty: Rick Prayag Pharm D Relationships with commercial
More informationPediatric Brain Tumors: Updates in Treatment and Care
Pediatric Brain Tumors: Updates in Treatment and Care Writer Classroom Rishi R. Lulla, MD MS Objectives Introduce the common pediatric brain tumors Discuss current treatment strategies for pediatric brain
More informationBRAJACTT. Protocol Code. Breast. Tumour Group. Dr. Karen Gelmon. Contact Physician
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer using DOXOrubicin and Cyclophosphamide followed by PACLitaxel and Trastuzumab (HERCEPTIN) Protocol Code Tumour Group Contact Physician
More informationCisplatin and Gemcitabine Bladder Cancer: Full and split dose
Systemic Anti Cancer Treatment Protocol Cisplatin and Gemcitabine Bladder Cancer: Full and split dose PROCTOCOL REF: MPHAUROCIG (Version No: 1.0) Approved for use in: Neoadjuvant and palliative indications
More information(7) VITAL SIGNS (8) LEVEL OF CONSCIOUSNESS (9) MENTAL STATUS (10) SPEECH (11) VISION (12) FUNDUS (PAPILLEDEMA)
Radiation Therapy Oncology Group Phase II CNS Lymphoma Follow-Up Form RTOG Study No. 1114 Case # Amended Data Yes INSTRUCTIONS: Submit this form as indicated in the protocol. All dates need to be recorded
More informationNeurosurgery Review. Mudit Sharma, MD May 16 th, 2008
Neurosurgery Review Mudit Sharma, MD May 16 th, 2008 Dr. Mudit Sharma, Neurosurgeon Manassas, Fredericksburg, Virginia http://www.virginiaspinespecialists.com Phone: 1-855-SPINE FIX (774-6334) Fundamentals
More informationSAALT3W Sarcoma Dr. Meg Knowling. Protocol Code Tumour Group Contact Physician
BCCA Protocol Summary for Etoposide, Ifosfamide-Mesna (SAIME) Alternating with vincristine, DOXOrubicin and Cyclophosphamide (with or without Mesna)(SAVAC or SAVACM) with Filgrastim Support at a THREE
More informationCase Report Antiangiogenic Therapy in the Treatment of Recurrent Medulloblastoma in the Adult: Case Report and Review of the Literature
Oncology Volume 2009, Article ID 247873, 4 pages doi:10.1155/2009/247873 Case Report Antiangiogenic Therapy in the Treatment of Recurrent Medulloblastoma in the Adult: Case Report and Review of the Literature
More informationLung Pathway Group Carboplatin & PO Vinorelbine in Non-Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Carboplatin & PO Vinorelbine in Non-Small Cell Lung Cancer (NSCLC) Indication: First line in radical/induction treatment in locally advanced NSCLC First line palliative treatment in
More information1. FBE,UEC, LFT 2. USS of eyes confirm intraocular origin, possible calcifications. 3. CT(if available) of eyes and head
Retinoblastoma PNG V2 Treatment Guidelines for PNG Retinoblastoma 01V1 Current aim of treatment is to preserve life, vision preservation is secondary at this time. Retinoblastoma remains intra ocular and
More informationAT TRIAGE. Alberta Acute Childhood Asthma Pathway: Evidence based* recommendations For Emergency / Urgent Care
1 1 Should the child be placed into the Pathway? Asthma Clinical Score (PRAM) Inclusion Children 1 year and 18 years of age who present with wheezing and respiratory distress, and have been diagnosed by
More informationADULT Updated: September 4, 2018
Updated: September 4, 2018 Regimen Reference Order ARIA: LYMP [R-CHOP alt. R-DHAP] Planned Course: Indication for Use: Every 21 days for 6 cycles (R-CHOP given on cycles 1, 3 and 5; R-DHAP given on cycles
More informationPAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY
PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic
More informationBrain Tumors. What is a brain tumor?
Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM GERM CELL TUMOURS CNS Site Group Germ Cell Tumours Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationBC Cancer Protocol for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel
BC Cancer Protocol for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel Protocol Code Tumour Group Contact Physician UGOOVBEVP Gynecologic Oncology Dr. Anna Tinker
More informationBRLAACDT. Protocol Code. Breast. Tumour Group. Dr. Karen Gelmon. Contact Physician
BCCA Protocol Summary for Treatment of Locally Advanced Breast Cancer using DOXOrubicin and Cyclophosphamide followed by DOCEtaxel and Trastuzumab (HERCEPTIN) Protocol Code Tumour Group Contact Physician
More informationCAR-T. Subrena Powell RN, MSN, BMTCN
CAR-T Subrena Powell RN, MSN, BMTCN Objectives Discuss the treatment timeline of a patient receiving CAR-T therapy Describe the side effects and management of symptoms of CAR-T therapy Treatment Schema
More informationSample. Affix patient label within this box.
Instructions for completing orders Complete pages 1-3 for General Inpatient Orders. All pathway compatible orders (indicated by ) within the General Inpatient Orders will be followed automatically. Optional
More informationStandard care plan for Carboplatin and Etoposide Chemotherapy References
CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Currency: Carboplatin/Etoposide Chemotherapy Clinical Guideline Standard Care Plan 2 Years Review date: Author(s): Standard care
More informationCity Pediatric Meet-Dec 2011 SPECTRUM OF HLH. Spectrum of HLH. Dr.Revathi Raj s unit, Apollo Children s Hospital.
City Pediatric Meet-Dec 2011 SPECTRUM OF HLH Spectrum of HLH Dr.Revathi Raj s unit, Apollo Children s Hospital. Case 1 4 month male child /thriving well Fever - 5 days with cough O/E hepatospenomegaly
More informationELIGIBILITY: small cell or neuroendocrine cancer (pure or mixed) administration of this protocol is restricted to BCCA Cancer Centres
BCCA Protocol Summary for Treatment of Small Cell or Neuroendocrine Carcinoma of Gynecologic System Origin using PACLitaxel, CISplatin, Etoposide and CARBOplatin with Radiation (GO 95 02) Protocol Code:
More informationAtypical Teratoid / Rhabdoid tumours. Information for parents and carers
Atypical Teratoid / Rhabdoid tumours Information for parents and carers Grace Kelly Ladybird Trust Atypical Teratoid / Rhabdoid tumours This publication is intended to supplement the advice given by your
More informationDocetaxel. Class: Antineoplastic agent, Antimicrotubular, Taxane derivative.
Docetaxel Class: Antineoplastic agent, Antimicrotubular, Taxane derivative. Indications: -Breast cancer: -Non small cell lung cancer -Prostate cancer -Gastric adenocarcinoma _Head and neck cancer Unlabeled
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationNephrotic Syndrome. Sara Alsharhan PharmD candidate, KSU 2014
Nephrotic Syndrome Sara Alsharhan PharmD candidate, KSU 2014 Outline Introduction Nephrotic syndrome classifications Signs and symptoms Diagnoses Management Complications Monitoring Case presentation Introduction
More informationBrain tumors: tumor types
Brain tumors: tumor types Tumor types There are more than 120 types of brain tumors. Today, most medical institutions use the World Health Organization (WHO) classification system to identify brain tumors.
More informationLeptomeningeal Carcinomatosis: Risks, Detection, and Treatment. Goldie Kurtz, MD, FRCPC Department of Radiation Oncology University of Pennsylvania
Leptomeningeal Carcinomatosis: Risks, Detection, and Treatment Goldie Kurtz, MD, FRCPC Department of Radiation Oncology University of Pennsylvania May 13, 2016 Disclosures None to declare 2 Outline Epidemiology
More informationExample Clinician Educational Material for Providers of Immune Effector Cellular Therapy
Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy Disclaimer: This example is just one of many potential examples of clinician education material that can be provided
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM EPENDYMOMA Last Revision Date July 2015 1 CNS Site Group Ependymoma Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2.
More informationGOOVIPPC. Protocol Code: Gynecology. Tumour Group: Paul Hoskins. Contact Physician: James Conklin. Contact Pharmacist:
BCCA Protocol Summary for Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer or Stage I Grade 3 or Stage II Grade 3 Papillary Serous Ovarian Cancer
More informationELIGIBILITY: Newly diagnosed acute promyelocytic leukemia (APL) with low to intermediate risk (WBC less than 10 x 10 9 /L)
BCCA Protocol Summary for First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide and Tretinoin (All-Trans Retinoic Acid) Protocol Code Tumour Group Contact
More informationBRAJACTTG. Protocol Code. Breast. Tumour Group. Dr. Karen Gelmon. Contact Physician
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide Followed by PACLitaxel and Trastuzumab (HERCEPTIN) Protocol Code Tumour Group
More informationCOG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Page 1 of 6 COG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT) FAST FACTS Eligibility Reviewed and Verified By
More informationTIP Paclitaxel, Ifosfamide and Cisplatin
Systemic Anti Cancer Treatment Protocol TIP Paclitaxel, Ifosfamide and Cisplatin PROTOCOL REF: MPHATIPGC (Version No: 1.0) Approved for use in: Second line treatment of germ cell tumours Dosage: Drug Dosage
More informationLung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Cisplatin & PO Vinorelbine in Non- Small Cell Lung Cancer (NSCLC) Indication: First line in radical/induction treatment in locally advanced NSCLC First line palliative treatment in advanced/metastatic
More informationLung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Cisplatin & IV Vinorelbine in Non- Small Cell Lung Cancer (NSCLC) Indication: First line in radical/induction treatment in locally advanced NSCLC First line palliative treatment in advanced/metastatic
More informationBC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using Weekly PACLitaxel and Trastuzumab (HERCEPTIN)
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using Weekly PACLitaxel and Trastuzumab (HERCEPTIN) Protocol Code: Tumour Group: Contact Physician: UBRAJTTW Breast Dr. Angela Chan ELIGIBILITY:
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II
MHD II, Session 11, Student Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II Session 11 April 11, 2016 STUDENT COPY MHD II, Session 11, Student Copy Page 2 CASE HISTORY 1 Chief complaint: Our baby
More informationPatient: Becky Smith DOB: 01/26/XXXX Age: 5 y/o Attending: Dr. D. Miles Allergies: NKA MR#: 203. Patient Chart #203 Becky Smith
Patient Chart #203 Becky Smith 1 Property of CSCLV CSCLV Rev: 06/04/2018 Chief Complaint: Abdominal pain. Informant: Parents. HISTORY & PHYSICAL HPI: Ill looking patient, healthy until 2 days ago when
More informationBC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using DOCEtaxel, CARBOplatin, and Trastuzumab (HERCEPTIN)
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using DOCEtaxel, CARBOplatin, and Trastuzumab (HERCEPTIN) Protocol Code Tumour Group Contact Physician BRAJDCARBT Breast Dr. Susan Ellard
More informationAll India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology
All India Institute of Medical Sciences, New Delhi, INDIA Department of Pediatric Surgery, Medical Oncology, and Radiology Clear cell sarcoma of the kidney- rare renal neoplasm second most common renal
More informationNeuro-oncology Update Andrew Kokkino, MD Medical Director, The Neurosciences Institute at Sacred Heart at Riverbend May 20, 2013
Neuro-oncology Update 2013 Andrew Kokkino, MD Medical Director, The Neurosciences Institute at Sacred Heart at Riverbend May 20, 2013 Case 1 58 year old man with recent facial droop and HA s Thin, cachectic
More informationLouisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust
Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced
More informationTHE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST
Outpatient Anti Cancer Treatment Handbook LCV Lomustine, Cisplatin, Vincristine Packer Regimen Repeated every 6 weeks for a maximum of 6 cycles Approved for use in: Medulloblastoma adjuvant therapy Dosage:
More informationEasy Trick to Spot Leukemia for Pediatricians
Easy Trick to Spot Leukemia for Pediatricians Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital Most Common Pediatric Cancers Age 0-14 Leukemia 32%
More information1/29/2014. Kimberly Johnson Hatchett, MD PGY-4 11/15/13
Kimberly Johnson Hatchett, MD PGY-4 11/15/13 History of Present Illness 14 month old previously healthy infant boy presented via EMS after being found by his mother to be breathing loudly and non-responsive.
More informationChildhood Central Nervous System Embryonal Tumors Treatment (PDQ )
1 di 18 06/07/2016 14.53 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationBC Cancer Protocol Summary for Palliative Therapy for Recurrent Malignant Gliomas Using Bevacizumab With or Without Concurrent Etoposide or Lomustine
BC Cancer Protocol Summary for Palliative Therapy for Recurrent Malignant Gliomas Using Bevacizumab With or Without Concurrent Etoposide or Lomustine Protocol Code Tumour Group Contact Physician CNBEV
More informationBrain and Spinal Cord Tumors in Children Early Detection, Diagnosis, and Staging
Brain and Spinal Cord Tumors in Children Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs
More informationBCCA Protocol Summary for Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum
BCCA Protocol Summary for Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum Protocol Code: Tumour Group: Contact Physician: HNAVFUP Head and Neck
More informationELIGIBILITY: Newly diagnosed acute promyelocytic leukemia (APL) with high risk (WBC more than 10 x 10 9 /L)
BC Cancer Protocol Summary for First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide, Tretinoin (All-Trans Retinoic Acid) and DAUNOrubicin Protocol Code
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy
More informationCD20-positive high-grade non-hodgkin Lymphoma in patients in which R-CHOP is not indicated
INDICATION CD20-positive high-grade non-hodgkin Lymphoma in patients in which R-CHOP is not indicated TREATMENT INTENT Curative or Disease Modification. PRE-ASSESSMENT 1. Ensure histology is confirmed
More informationVincristine Ifosfamide Doxorubicin Etoposide (VIDE) Sarcoma
Systemic Anti Cancer Treatment Protocol Vincristine Ifosfamide Doxorubicin Etoposide (VIDE) Sarcoma PROTOCOL REF: MPHAVIDE (Version No: 1.0) Approved for use in: Ewings sarcoma Desmoplastic small round
More informationBrain Meninges, Ventricles and CSF
Brain Meninges, Ventricles and CSF Lecture Objectives Describe the arrangement of the meninges and their relationship to brain and spinal cord. Explain the occurrence of epidural, subdural and subarachnoid
More informationVentriculo-Peritoneal/ Lumbo-Peritoneal Shunts
Ventriculo-Peritoneal/ Lumbo-Peritoneal Shunts Exceptional healthcare, personally delivered Ventriculo-Peritoneal/ Lumbo-Peritoneal Shunts What is hydrocephalus? Hydrocephalus is the build up of an excess
More informationFOCUSING ON TUMORS. Ependymoma
FOCUSING ON TUMORS Ependymoma A Word About ABTA Founded in 1973, the not-for-profit American Brain Tumor Association has a proud history of funding research, providing patient services, and educating people
More informationStroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine
Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates
More informationCycle 1 PERTuzumab (day 1) and trastuzumab (day 2) loading doses: Drug Dose BC Cancer Administration Guideline
BC Cancer Protocol Summary for Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab (HERCEPTIN), and PACLItaxel as First-Line Treatment for Advanced Breast Cancer Protocol Code:
More informationManagement of carcinomatous meningitis in a patient with advanced lung adenocarcinoma
Management of carcinomatous meningitis in a patient with advanced lung adenocarcinoma Clinical Case Presentation Emilie Le Rhun Centre Hospitalier Régional et Universitaire (CHRU) de Lille Neurochirurgie
More informationProtocol Abstract and Schema
Protocol Abstract and Schema Phase II study of Bevacizumab plus Irinotecan (Camptosar ) in Children with Recurrent, Progressive, or Refractory Malignant Gliomas, Diffuse/Intrinsic Brain Stem Gliomas, Medulloblastomas,
More informationUpward spinal coning: impaction of occult spinal tumours following relief of hydrocephalus
Journal of Neurology, Neurosurgery, and Psychiatry 1984;47: 386-390 Upward spinal coning: impaction of occult spinal tumours following relief of hydrocephalus RASHID JOOMA, RICHARD D HAYWARD From the Departments
More informationCNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
CNS TUMORS D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) CNS TUMORS The annual incidence of intracranial tumors of the CNS ISmore than intraspinal tumors May be Primary or Secondary
More informationSometimes we get it wrong. Sheila Weitzman MB BCh
Sometimes we get it wrong Sheila Weitzman MB BCh Pediatric cancer Survival ~80% One in five children still die Second commonest cause of death in developed countries Delay in diagnosis in children with
More informationCombining Lurbinectedin and Doxorubicin The UCLH Experience in Small Cell Lung Cancer
Combining Lurbinectedin and Doxorubicin The UCLH Experience in Small Cell Lung Cancer Dr Martin Forster MD PhD Clinical Senior Lecturer in Experimental Cancer Medicine Consultant in Medical Oncology UCL
More informationCisplatin + Etoposide IV / Oral therapy followed by Chemo-radiotherapy in Small Cell Carcinoma of the Cervix
Cisplatin + Etoposide IV / Oral therapy followed by Chemo-radiotherapy in Small Cell Carcinoma of the Cervix Indication: Neoadjuvant chemotherapy followed by Chemo-radiotherapy in Small Cell Carcinoma
More informationBrain and Spine Tumors
Brain and Spine Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases
More informationEtiology based definitions for adult malnutrition: Role of inflammation A systematic approach to nutrition assessment
Etiology based definitions for adult malnutrition: Role of inflammation A systematic approach to nutrition assessment Gordon L Jensen, MD, PhD Penn State University University Park, PA Objectives Review
More informationBC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine
BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine Protocol Code Tumour Group Contact Physician UGOOVBEVV Gynecologic Oncology Dr.
More informationUnderstanding Blood Tests
PATIENT EDUCATION patienteducation.osumc.edu Your heart pumps the blood in your body through a system of blood vessels. Blood delivers oxygen and nutrients to all parts of the body. It also carries away
More informationLeptomeningeal metastasis: management and guidelines. Emilie Le Rhun Lille, FR Zurich, CH
Leptomeningeal metastasis: management and guidelines Emilie Le Rhun Lille, FR Zurich, CH Definition of LM LM is defined as the spread of tumor cells within the leptomeninges and the subarachnoid space
More informationNeuroblastoma. Elizabeth Roberts. Data Coordinator CIBMTR Data Managers Mentor. Tandem Meeting February 18
Neuroblastoma Elizabeth Roberts Data Coordinator CIBMTR Data Managers Mentor Tandem Meeting February 18 Objectives Know what neuroblastoma is, how it is diagnosed, and how it is treated Complete form 2026:
More informationBCCA Protocol for Primary Treatment of Metastatic or Recurrent Cancer of the Cervix with Bevacizumab, CARBOplatin and PACLitaxel
BCCA Protocol for Primary Treatment of Metastatic or Recurrent Cancer of the Cervix with Bevacizumab, CARBOplatin and PACLitaxel Protocol Code Tumour Group Contact Physician GOCXCATB Gynecologic Oncology
More informationSubject ID: I N D # # U A * Consent Date: Day Month Year
IND Study # Eligibility Checklist Pg 1 of 15 Instructions: Check the appropriate box for each Inclusion and Exclusion Criterion below. Each criterion must be marked and all protocol criteria have to be
More informationNature and Science 2017;15(7) Surgical Options for Treatment of Posterior Fossa Tumors with Hydrocephalus
Surgical Options for Treatment of Posterior Fossa Tumors with Hydrocephalus Mohamed Mahmoud Abohashima; Ahmed Mohamed Hasan Salem; Magdy Asaad El-Hawary Neurosurgery department, Faculty of Medicine, Al-azhar
More informationPediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University
Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University SHOCK Definition: Shock is a syndrome = inability to provide sufficient oxygenated blood to tissues. Oxygen
More informationFAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated
Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly
More informationPLACE LABEL HERE. Radiation Therapy Oncology Group Phase II Nasopharyngeal Cancer Follow-Up Form
F1 AMENDED DATA Radiation Therapy Oncology Group Phase II Nasopharyngeal Cancer Follow-Up Form YES No INSTRUCTIONS: Submit this form at the appropriate follow-up interval and at death Dates are recorded
More informationX M/ (R) Dose adjusted (DA)-EPOCH-R
X M/ (R) adjusted (DA)-EPOCH-R Indication High-risk CD20+ diffuse large B cell lymphoma especially C-MYC and BCL-2 activated (i.e. double hit lymphoma) and mediastinal sclerosing (thymic) large B cell
More informationAcute Stroke with Alteplase Administration Order Set
Review Due Date: 2017 October PATIENT CARE DERS Weight: Adverse Reactions or Intolerances Drug No Yes (list) Food No Yes (list) _ Latex No Yes Admission Admit to Neurology service: Dr. Critical Care Diagnosis:
More informationPREHYDRATION: 1000 ml NS with potassium chloride 20 meq and magnesium sulphate 2 g IV over 1 hour prior to CISplatin
BC Cancer Protocol Summary for Treatment of Newly Diagnosed Nasal, Extranodal Natural Killer (NK) or T-cell lymphoma, using Concurrent Radiation and weekly CISplatin followed by Etoposide, Ifosfamide,
More informationTumors of the Nervous System
Tumors of the Nervous System Peter Canoll MD. PhD. What I want to cover What are the most common types of brain tumors? Who gets them? How do they present? What do they look like? How do they behave? 1
More informationJune 2009 Respiratory Committee CALGB 30610
30610 Phase III comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide Activated: March 15, 2008 Study Chairpersons: J. Bogart
More informationHematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma
Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Policy Number: Original Effective Date: MM.07.013 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 02/24/2012
More informationFrom a suspicious cystic pineal gland to pineoblastoma in a patient with familial unilateral retinoblastoma
From a suspicious cystic pineal gland to pineoblastoma in a patient with familial unilateral retinoblastoma Marcus C de Jong, Annette C Moll, Sophia Göricke, Paul van der Valk, Wijnanda A Kors, Jonas A
More informationThe Brain and Spinal Cord 33
The Brain and Spinal Cord 33 shiao Y. Woo TOLERANCE OF THE CENTRAL NERVOUS SYSTEM TO IRRADIATION Postirradiation Cerebral Necrosis Postirradiation Myelopathy Other Late Effects CENTRAL NERVOUS SYSTEM NEOPLASMS
More informationBone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital
Bone Metastases Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital 1 Outline Pathophysiology Signs & Symptoms Diagnosis Treatment Spinal Cord Compression 2 General Information
More informationADPedKD: detailed description of data which will be collected in this registry
ADPedKD: detailed description of data which will be collected in this registry I. Basic data 1. Patient ID: will be given automatically 2. Personal information - Date of informed consent: DD/MM/YYYY -
More information